PHILADELPHIA, March 23, 2017 -- Hill International (NYSE:HIL), the global leader in managing construction risk, announced today that the sale of its Construction Claims Group is now expected to occur on or about April 30, 2017. The company had previously announced that it expected that the closing of the sale would occur on March 31, 2017. While good progress continues to be made, it has been agreed between the parties that further time will be required to complete the necessary steps to close the transaction on March 31, 2017.
Hill International, with 4,300 professionals in 100 offices worldwide, provides program management, project management, construction management, construction claims and other consulting services primarily to the buildings, transportation, environmental, energy and industrial markets. Engineering News-Record magazine recently ranked Hill as the eighth largest construction management firm in the United States. For more information on Hill, please visit our website at www.hillintl.com.
Certain statements contained herein may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is our intent that any such statements be protected by the safe harbor created thereby. Except for historical information, the matters set forth herein including, but not limited to, any statements concerning the closing of the sale of our Construction Claims Group; any projections of revenues, earnings or other financial items; any statements concerning our plans, strategies and objectives for future operations; and any statements regarding future economic conditions or performance, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although we believe that the expectations, estimates and assumptions reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Important factors that could cause our actual results to differ materially from estimates or projections contained in our forward-looking statements are set forth in the Risk Factors section and elsewhere in the reports we have filed with the Securities and Exchange Commission, including that unfavorable global economic conditions may adversely impact our business, our backlog may not be fully realized as revenue, our expenses may be higher than anticipated, and the closing of the sale of our Construction Claims Group may be delayed or cancelled. We do not intend, and undertake no obligation, to update any forward-looking statement.
Hill International, Inc.
John P. Paolin
Senior Vice President of Marketing and
Corporate Communications
(215) 309-7710
[email protected]
The Equity Group Inc.
Devin Sullivan
Senior Vice President
(212) 836-9608
[email protected]
(HIL-G)


BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 



